Lagnason, Samuel O.
HRN: 14-52-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFTRIAXONE 1G (VIAL)
05/24/2022
05/31/2022
IV
1g
Q 12H
Femoral Neck Fracture, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes